Effective oral delivery of insulin in animal models using vitamin B12-coated dextran nanoparticles

Author(s): Chalasani KB, Russell-Jones GJ, Jain AK, Diwan PV, Jain SK

Abstract

The potential utility of vitamin B12 carrier system for the oral delivery of conjugated peptides/proteins and enhancement of nanoparticles (NPs) transport has been demonstrated. The present study aims to optimize the effectiveness of VB12-NPs conjugates using different levels of cross-linking, linked with different VB(12)-coatings and evaluates in animal models to investigate an efficient insulin carrier. Amino alkyl VB12 derivatives suitable for oral delivery were synthesized at 5'hydoxy ribose and e-propionamide sites via carbamate and ester/amide linkages, and were coupled to succinic acid modified dextran NPs of varied cross-linking. VB12 binding was confirmed by XPS analysis, and was quantified by HPLC (4.0 to 5.7% w/w of NPs). These polydisperse NPs conjugates showed higher size, high insulin entrapment and faster insulin release with low levels of cross-linking. These VB12-NPs conjugates (150-300 nm) showed profound (70-75% blood glucose reductions) and prolonged (54 h) anti-diabetic effects with biphasic behaviour in STZ diabetic rats. NPs with the low levels of cross-linking were found to be superior carriers, and were more effective with VB12 derivatives of carbamate linkage. The pharmacological availability relative to SC insulin was found to be 29.4%, which was superior compared to NPs conjugate of ester linked VB12 (1.5 fold) and relatively higher cross-linked particles (1.1 fold). Further, the NPs carrier demonstrated a similar oral insulin efficacy in congenital diabetic mice (60% reduction at 20 h). Significant quantities of plasma insulin were found in both animal models (231 and 197 muIU/ml). At two investigated doses, the carrier system shows dose response. Pre-dosing with a large excess of free VB12 minimized the observed activity, indicating predominance of VB12 mediated uptake. It is concluded that VB12-dextran NPs conjugate is a viable carrier for peroral insulin delivery to treat diabetics.

Similar Articles

Insulin

Author(s): Beals J, Brader M, De Felippis M, Kovach P

Diagnosis and Classification of Diabetes Mellitus

Author(s): American Diabetes Association

Oral insulin delivery: how far are we? J Diabetes Sci Technol 7: 520-531

Author(s): Fonte P, Araújo F, Reis S, Sarmento B

Insulin: discovery and controversy

Author(s): Rosenfeld L

Polymeric hydrogels for oral insulin delivery

Author(s): Chaturvedi K, Ganguly K, Nadagouda MN, Aminabhavi TM

Dose response to oral insulin capsules in fasting, healthy subjects

Author(s): Eldor R, Arbit E, Schurr D, Kidron M, Hersko A

Injectable nano-network for glucose-mediated insulin delivery

Author(s): Gu Z, Aimetti AA, Wang Q, Dang TT, Zhang Y, et al.

Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin

Author(s): Zhang N, Ping Q, Huang G, Xu W, Cheng Y, et al.

Developments in polymeric devices for oral insulin delivery

Author(s): Babu VR, Patel P, Mundargi RC, Rangaswamy V, Aminabhavi TM

Nanoparticle strategies for the oral delivery of insulin

Author(s): Damgé C, Reis CP, Maincent P

Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach

Author(s): des Rieux A, Fievez V, Garinot M, Schneider YJ, Préat V

Nanosphere based oral insulin delivery

Author(s): Carino GP, Jacob JS, Mathiowitz E

Cross-linked chitosan microspheres for oral delivery of insulin: Taguchi design and in vivo testing

Author(s): Jose S, Fangueiro JF, Smitha J, Cinu TA, Chacko AJ, et al.

Oral insulin delivery by means of solid lipid nanoparticles

Author(s): Sarmento B, Martins S, Ferreira D, Souto EB

Nanomedicine for diabetes treatment

Author(s): Sung HW, Sonaje K, Feng SS

Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery

Author(s): Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MH, et al.

pH-Sensitive oral insulin delivery systems using Eudragit microspheres

Author(s): Mundargi RC, Rangaswamy V, Aminabhavi TM

Evaluation of an oral insulin formulation in normal and diabetic rats

Author(s): Najafzadeh H, Kooshapur H, Kianidehkordi F

Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery

Author(s): Pridgen EM, Alexis F, Kuo TT, Levy-Nissenbaum E, Karnik R, et al.

Insulin: A new era for an old hormone

Author(s): Sabetsky V, Ekblom J